Effects of switching from somatropin to somapacitan on thyroid hormone levels in adult growth hormone deficiency: A pilot study
- 20 June 2026
- journal article
- Published by Elsevier in Growth Hormone & IGF Research
- Vol. 85, 101720
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 TrialThe Journal of Clinical Endocrinology & Metabolism, 2020
- Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trialEuropean Journal of Endocrinology, 2018
- Effects of growth hormone on thyroid function are mediated by type 2 iodothyronine deiodinase in humansEndocrine, 2017
- The classic pathways of thyroid hormone metabolismMolecular and Cellular Endocrinology, 2017
- Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS methodEndocrine Journal, 2012
- Long-Term Effects of Growth Hormone Replacement Therapy on Thyroid Function in Adults with Growth Hormone DeficiencyThyroid®, 2008
- Thyroid Hormone Replacement for Central Hypothyroidism: A Randomized Controlled Trial Comparing Two Doses of Thyroxine (T4) with a Combination of T4 and TriiodothyronineThe Journal of Clinical Endocrinology & Metabolism, 2007
- Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patientsClinical Endocrinology, 2006
- Thyroid Function Is Associated with Components of the Metabolic Syndrome in Euthyroid SubjectsThe Journal of Clinical Endocrinology & Metabolism, 2006
- Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose‐dependent manner and suppresses circadian thyrotrophin levels: studies in GH‐deficient adultsClinical Endocrinology, 1994